UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000037807
Receipt No. R000043112
Scientific Title The significance of preoperative antimicrobial treatment in patients undergoing ureteroscopy with positive urine culture
Date of disclosure of the study information 2019/08/26
Last modified on 2021/02/25 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title The significance of preoperative antimicrobial treatment in patients undergoing ureteroscopy with positive urine culture
Acronym The significance of preoperative antimicrobial treatment in patients undergoing ureteroscopy with positive urine culture
Scientific Title The significance of preoperative antimicrobial treatment in patients undergoing ureteroscopy with positive urine culture
Scientific Title:Acronym The significance of preoperative antimicrobial treatment in patients undergoing ureteroscopy with positive urine culture
Region
Japan

Condition
Condition urolithiasis
Classification by specialty
Urology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate the efficacy of preoperative antimicrobial treatment
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes intraoperative urine culture
The rate of adverse event, especially fever and sepsis after ureteroscopy
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients who underwent ureteroscopy in our center since 2019 April were included.
Key exclusion criteria We excluded patients who underwent continuous multiple ureteroscopy.
Target sample size 100

Research contact person
Name of lead principal investigator
1st name Ryoji
Middle name
Last name Takazawa
Organization Tokyo Metropolitan Ohtsuka hospital
Division name Division of urology
Zip code 170-8476
Address Minami-ohtsuka 2-8-1, Toshima-ku, Tokyo, Japan
TEL 03-3941-3211
Email ryoji_takazawa@tmhp.jp

Public contact
Name of contact person
1st name Masaki
Middle name
Last name Kobayashi
Organization Tokyo Metropolitan Ohtsuka hospital
Division name Division of urology
Zip code 170-8476
Address Minami-ohtsuka 2-8-1, Toshima-ku, Tokyo, Japan
TEL 03-3941-3211
Homepage URL
Email angel_sapporo_0329@yahoo.co.jp

Sponsor
Institute Tokyo Metropolitan Ohtsuka hospital
Institute
Department

Funding Source
Organization Tokyo Metropolitan Ohtsuka hospital
Organization
Division
Category of Funding Organization Local Government
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Tokyo Metropolitan Ohtsuka hospital
Address Minami-ohtsuka 2-8-1, Toshima-ku, Tokyo, Japan
Tel 03-3941-3211
Email angel_sapporo_0329@yahoo.co.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2019 Year 08 Month 26 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 120
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2019 Year 03 Month 01 Day
Date of IRB
2019 Year 08 Month 16 Day
Anticipated trial start date
2019 Year 04 Month 01 Day
Last follow-up date
2021 Year 02 Month 25 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information No extra information

Management information
Registered date
2019 Year 08 Month 26 Day
Last modified on
2021 Year 02 Month 25 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000043112